Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

The Medicines Company

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of The Medicines Company's 2013 cardiovasular sales performance.

The Medicines Company

Novartis acquires The Medicines Company for $9.7bn following takeover rumours

Novartis acquires The Medicines Company for $9.7bn following takeover rumours MedCo's cholesterol lowering inclisiran main attraction in planned acquisition. Last week, The Medicines Company surged on reported rumours that Novartis was planning to acquire it – reports that have now been ... The prospect of bringing inclisiran to

The Medicines Company surges on rumours of Novartis takeover

The Medicines Company surges on rumours of Novartis takeover Shares in The Medicines Company have leapt on rumours that Novartis is eyeing a takeover of the company and its promising new cardiovascular drug inclisiran. ... Novartis – or indeed another party – may be prepared to pay for the company.

TMC preps filings for inclisiran after final phase 3 trials hit the mark

TMC preps filings for inclisiran after final phase 3 trials hit the mark Less frequent dosing schedules could prove an advantage over rivals. The Medicines Company has positive top-line data from the last of its phase 3 trials of inclisiran, setting up regulatory ... The ORION-9 and ORION-10 data will be reported in full at

TMC’s full data for inclisiran impresses at ESC

TMC’s full data for inclisiran impresses at ESC Marketing applications expected before end of year. The Medicine’s Company has unveiled the impressive detailed results of its LDL-C lowering drug inclisiran at the ESC 2019, setting up a ... By lowering LDL levels, or ‘bad’ cholesterol, the

TMC rockets on data for twice-yearly cholesterol drug inclisiran

TMC rockets on data for twice-yearly cholesterol drug inclisiran Shares up 14% following announcement. The Medicines Company’s big gamble on cholesterol-lowering drug inclisiran looks like to could be about to pay off with a US filing later this ... Shares in the company closed up 14% after the ORION-11 data was

[ Previous 5 results ] 1 2 3 4 5 6 7 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...
Top 10 Tips for Optimizing Asynchronous Virtual Meetings
Natalie Yeadon shares her expertise on how you can make the most out of your asynchronous virtual meetings and ask effective questions virtually....

Infographics